Peels and Masks
Peels and Masks category supports clinics that run exfoliation and mask protocols. Inventory is shipped from the US and intended for professional handling. This hub groups peeling solutions, peel pads, enzyme exfoliants, and mask formats used in aesthetic care.
Use filters to compare ingredient families, packaging, and protocol fit. The links below support product review and staff education planning.
Peels and Masks in Professional Skin Care
Professional peels and masks are used to support controlled surface renewal. Many products target the stratum corneum (outer skin layer) through keratolytic action (dead-skin loosening). Formulas vary by acid type, vehicle, pH, and contact-time requirements.
Mask systems can be clay-based, gel-based, cream-based, or sheet-based. They may focus on oil absorption, hydration support, or temporary barrier comfort. In clinic workflows, selection often depends on tolerance history and post-procedure planning.
| Format | Common actives | Operational notes |
|---|---|---|
| Alpha hydroxy acid peels | Glycolic acid, lactic acid | Often higher irritation potential; review sun-sensitivity precautions. |
| Beta hydroxy acid peels | Salicylic acid | Comedolytic (pore-clearing); consider oily-skin protocols and sensitivities. |
| Enzyme exfoliants | Proteolytic enzymes | Typically lower sting; still needs contact-time consistency and rinse steps. |
| Mask and pack products | Clays, charcoal, humectants | Occlusive (water-loss limiting) products may feel heavy on acne-prone skin. |
Items are sourced through vetted distributors with documented supply chains.
What You’ll Find in This Category
This Peels and Masks collection covers professional exfoliating peel solutions, peel pads, resurfacing masks, and supportive mask formats. Product pages summarize format, intended use setting, and manufacturer-provided handling details when available.
Clinics looking for in-protocol peel systems can review options such as PRX T33 Wiqo and BioRePeelCl3 FND. Background context is available in related content like PRX T33 Treatment and BioRePeelCl3 Chemical Peels.
- Facial peels by acid family, including AHA and BHA approaches.
- Enzyme-based exfoliants that rely on non-acid protease activity.
- Mask formats for oil control, hydration support, and post-service comfort.
- Adjunct topical care that may pair with resurfacing protocols.
For pigment-focused workflows, clinics may also reference Azelac RU Liposomal Serum and the companion overview Azelac RU Skin Health.
How to Choose
When standardizing Peels and Masks across providers, clinics often start with workflow goals. Define whether the priority is exfoliation intensity, oil reduction, hydration support, or tone refinement. Then align formula class with typical downtime tolerance and supervision level.
Selection checklist for clinic teams
- Primary indication: acne, dyschromia, texture, or photoaging patterns.
- Active class: glycolic acid peel, lactic acid peel, or salicylic acid peel.
- Delivery: bottled peeling solution versus peel pads for dosing consistency.
- Neutralization needs and rinse steps, as stated in the IFU.
- Vehicle and sensorial profile, including alcohol content and fragrance load.
- Mask type: clay face mask, charcoal mask, gel mask, or cream pack.
- Barrier-support ingredients like humectants and film formers.
- Packaging: single-use, multi-dose, pump, or ampoule control.
- Compatibility with post-service photoprotection and daily care routines.
Why it matters: Standardized peel steps reduce documentation gaps across multi-provider teams.
Access is designed for licensed clinics and healthcare professionals.
Safety and Use Notes
Safety screening and standardized steps should be defined at the protocol level. For Peels and Masks, most issues relate to irritant dermatitis, over-exfoliation, or unexpected sensitivity. Avoid conflating cosmetic masks with medical-grade resurfacing systems during intake and consent workflows.
Key risk areas include periorbital exposure, compromised barrier, recent procedures, and active infection. Staff should follow manufacturer IFUs and internal clinical governance policies. For general background, see American Academy of Dermatology guidance on chemical peels. For AHA-related sun sensitivity context, review FDA information on alpha hydroxy acids.
Operational safety checks
- Confirm product identity, lot, and expiration before room stocking.
- Standardize contact time, removal steps, and post-service skin support.
- Separate eye-area products from face peels during room setup.
- Document reactions using consistent descriptors and photo protocols.
- Escalate adverse events per clinic policy and local regulations.
Clinic Ordering and Compliance Notes
Peels and Masks may be stocked for professional services and supervised retail plans. Ordering is restricted to licensed clinics and healthcare professionals. Account verification and documentation requirements may apply based on product type.
Receiving processes should include package inspection and inventory logging. Store products per labeled conditions and rotate stock by expiration date. For protocols that depend on daily photoprotection, clinics may cross-reference Repaskin Fluid Invisible SPF during regimen planning.
Quick tip: Save the manufacturer IFU PDFs in the clinic shared drive.
Listings focus on authentic, brand-name products.
This content is for informational purposes only and is not a substitute for professional medical advice.
FILTERS
Price
Product categories
Brands
BioRePeelCl3® FND
Ferulac Nano Additive Mist
Ferulac Peel Plus
Fillmed® Bright Peel Normal Skin
Filorga® Bright Peel (Normal Skin)
Filorga® Light Peel (Sensitive Skin)
Filorga® Post Peel
Filorga® Pre Pell
Filorga® Time Peel (Normal Skin)
Frequently Asked Questions
What types of peels are included in this category?
This category groups multiple peel formats used in aesthetic settings. Common groupings include AHA-based options like glycolic and lactic acids, and BHA-based options like salicylic acid. Some listings are enzyme exfoliants rather than acid peels. Formats can include bottled solutions, single-use ampoules, and peel pads. Product pages typically note the format, intended setting, and any manufacturer handling notes. Clinics should align selection with internal protocols and staff training.
How do peel pads differ from bottled peeling solutions?
Peel pads are pre-saturated applicators that can help standardize product pickup. They may reduce variability from decanting and dosing in multi-room workflows. Bottled peeling solutions offer more flexibility in application methods, but they rely on consistent dispensing practices. Both formats still require clear contact-time standards and removal steps from the manufacturer IFU. Clinics often choose based on workflow control, room turnover needs, and inventory management preferences.
What should clinics check when comparing mask formats?
Mask comparison usually starts with the functional goal and vehicle. Clay and charcoal formats often emphasize oil absorption and a matte finish. Gel and cream masks can support hydration and comfort, depending on humectants and occlusive agents. Clinics should also review fragrance, alcohol content, and rinse-off requirements. Packaging matters for infection control and waste tracking. For consistency, clinics can define one or two mask types per service line and document when substitutions occur.
Where can staff find background reading linked to this category?
Several content pages provide context on peel-related modalities and ingredient concepts. Examples include PRX and BioRePeel overview pages, plus posts that discuss hyperpigmentation and photoaging workflows. These resources can support onboarding, scripting, and protocol documentation. They are informational and should not replace manufacturer instructions for use. Clinics can use them to build shared language around peel classes, expected transient reactions, and basic post-service care considerations.
What safety references should teams review before implementing chemical peels?
Teams should start with the manufacturer IFU for each peel system, then align it with internal policies. Many clinics also keep a concise adverse-event response workflow and standardized documentation fields. External references can help frame general risks and contraindication categories, but they do not replace product-specific instructions. Reputable sources include professional dermatology organizations and regulator materials on ingredient safety topics. Staff education should be refreshed when protocols or product lines change.